Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Trospium Chloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,224Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BMS’ Cobenfy tipped to be top dog in growing schizophrenia space
    BMS’ Cobenfy tipped to be top dog in growing schizophrenia space

    19 Dec 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/analysts-tip-bms-cobenfy-be-top-dog-growing-schizophrenia-market

    FIERCE PHARMA
    19 Dec 2024
    Share Share
    Bristol Myers Presents Long-term EMERGENT Data in Schizophrenia
    Bristol Myers Presents Long-term EMERGENT Data in Schizophrenia

    31 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241031061541/en

    BUSINESSWIRE
    31 Oct 2024
    Share Share
    Bristol Myers Squibb to Present Data at Psych Congress 2024
    Bristol Myers Squibb to Present Data at Psych Congress 2024

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241025717199/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    BMS' schizophrenia gem Cobenfy was salvaged from the scrapheap
    BMS' schizophrenia gem Cobenfy was salvaged from the scrapheap

    07 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/bmss-newly-approved-schizophrenia-drug-cobenfy-what-long-strange-trip-its-been

    FIERCE PHARMA
    07 Oct 2024
    Share Share
    Segal Trials Key In FDA Approval Of Cobenfy For Schizophrenia
    Segal Trials Key In FDA Approval Of Cobenfy For Schizophrenia

    04 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241003050509/en

    BUSINESSWIRE
    04 Oct 2024
    Share Share
    US FDA approves Bristol Myers' schizophrenia drug
    US FDA approves Bristol Myers' schizophrenia drug

    27 Sep 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-drug-2024-09-26/

    REUTERS
    27 Sep 2024
    Share Share